Talphera

About:

Talphera focuses on the development and commercialization of therapies for the treatment of pain and other conditions.

Website: https://talphera.com/

Top Investors: Hercules Capital, Nantahala Capital Management, Oxford Finance LLC, Skyline Ventures

Description:

Talphera is a specialty pharmaceutical company developing and commercializing therapies in medically supervised settings. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute postoperative pain in hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures.